Address 503/504, 5th Floor, Hubtown Solaris,
N.S.Phadke Marg, Andheri (East), Mumbai- 400069, India
Phone: (+91) 22 6105 6105
Fax: (+91) 22 6105 6106
Area Served: Worldwide
No of employees:
Manufacture of other chemical products
Unosource Pharma Limited is a Public Company incorporated at Registrar of Companies RoC-Delhi on 18-12-13.
Unosource Pharma Limited is majorly involved in Public and categorised as Company Limited by Shares and Indian Non-Government Company.
Unosource Pharma Limited is registered in the state of Delhi and has its registered address at 305, Third Floor, C-Block, Plot No. 5 Mohan Place, Saraswati Vihar Delhi Delhi India 110034
Corporate Identification Number (CIN) of Unosource Pharma Limited is U24233DL2013PLC262364.
Uno Source is committed to improving the health of patients worldwide through development, production and marketing of innovative pharmaceutical products. It is dedicated to ensuring that our research, development strategy and results are conducted in a transparent and shared way and in a collaborative manner with researchers, health authorities and especially patients. Specialized in-house and DSIR recognized unit is the backbone of the company. State-of-the -art, sophisticated lab is well-equipped which help us develop quality products for the healthcare industry.
It is pursuing robust organic growth. This strategy is complemented by key alliances with exemplary global marketing partners. It is striving towards better health for patients worldwide through leading innovation in medicine, distinctive marketing capabilities, state of the art manufacturing facilities, broad product portfolio, deep understanding of pharmaceutical regulations, and strong partnerships and affiliations,. As a recognized WHO GMP approved/PICS compliant manufacturer for pharmaceuticals, we endeavor to stick to WHO / PICS quality standards.
The company have a comprehensive presence in the global marketplace, with formulations available in more than 25 countries worldwide. Our eight state-of-the-art manufacturing facilities enable us to produce more than 5000 plus bioequivalence finished formulations (medicines), which are accredited and approved by various regulatory authorities across the globe.